Cytosolic PSD-95 interactor (cypin), the primary guanine deaminase in the brain, plays key roles in shaping neuronal circuits and regulating neuronal survival. Despite this pervasive role in neuronal function, the ability for cypin activity to affect recovery from acute brain injury is unknown. A key barrier in identifying the role of cypin in neurological recovery is the absence of pharmacological tools to manipulate cypin activity in vivo. Here, we use a small molecule screen to identify two activators and one inhibitor of cypin's guanine deaminase activity. The primary screen identified compounds that change the initial rate of guanine deamination using a colorimetric assay, and secondary screens included the ability of the compounds to protect neurons from NMDAinduced injury and NMDA-induced decreases in frequency and amplitude of miniature excitatory postsynaptic currents. Hippocampal neurons pretreated with activators preserved electrophysiological function and survival after NMDA-induced injury in vitro, while pretreatment with the inhibitor did not. The effects of the activators were abolished when cypin was knocked down. Administering either cypin activator directly into the brain one hour after traumatic brain injury significantly reduced fear conditioning deficits 5 days after injury, while delivering the cypin inhibitor did not improve outcome after TBI. Together, these data demonstrate that cypin activation is a novel approach for improving outcome after TBI and may provide a new pathway for reducing the deficits associated with TBI in patients.
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Introduction
Traumatic brain injury (TBI) is defined as brain dysfunction caused
by an outside force applied to the head and is currently the leading cause of death for people under the age of 45 in the US. TBI is associated with disability, early-onset dementia, cognitive disorders, mental illness, and epilepsy (Nolan, 2005; Pearn et al., 2017; Prins et al., 2013) . Nearly all of the approaches for treating TBI concentrate on protecting against neuronal degeneration, or alternatively, promoting neuronal survival (reviewed in (Werner and Stevens, 2015) ). Although a common consequence of TBI is an alteration of neural circuits within injured brain regions, far fewer therapeutic approaches are designed to manipulate key molecules that shape neuronal circuits.
Although electrical stimulation of neural circuits offers one approach for repairing the brain after traumatic injury, these approaches do not offer a direct method to precisely target molecules that may actively reconstruct damaged circuits. One of the important ways that neuronal circuits are modified during neurological disease and injury is through synaptic plasticity and dendritic spine remodeling (Campbell et al., 2012a) , which together affect neuronal connectivity (Han et al., 2014; Han et al., 2016; Han et al., 2015) and lead to adverse neuroplastic events (Tomaszczyk et al., 2014) . Synaptic plasticity is a primary mechanism for remodeling neural circuits during learning acquisition and memory storage (Zucker and Regehr, 2002) . At the structural level, plasticity can appear with enhancement or shrinkage of the dendritic spine (Lai and Ip, 2013) and an accompanying change to α-amino-3-https://doi.org/10.1016/j.nbd.2018.07.019 Received 31 May 2018; Received in revised form 6 July 2018; Accepted 17 July 2018
